RADIOPHARM THERANOSTICS LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.08
-3.26%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-27.0%
3 months
-65.3%
6 months
-75.5%
1 year
-79.1%
Year to date
-79.3%
52-week range
$0.90 – $10.63
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$12.8M
P/E
-0.3
P/B
0.7
P/S
6.7
Revenue
$2.77M
Net income
-$54.53M
Diluted EPS
-5.37
Gross margin
9.50%
Net margin
-1970.00%
Return on equity
-157.00%
Total debt
$25.77M
Cash
$4.14M
Free cash flow
-$52.78M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Jun 30, 2026 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent RADX news
All market newsNo ticker-linked stories are in the current archive.